Comparison of the Clinical and Immunohistochemical Features, Including Anaplastic Lymphoma Kinase (ALK) and p53, in Inflammatory Myofibroblastic Tumours

Author： Jiang You-Hua   Cheng Bo   Ge Ming-Hua   Cheng Ye   Zhang Gu  

Publisher： Field House Publishing

ISSN： 0300-0605

Source： The Journal of International Medical Research, Vol.37, Iss.3, 2009-05, pp. : 867-877

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Anaplastic Lymphoma Kinase Expression and Prognosis in Inflammatory Myofibroblastic Tumours of the Maxillary Sinus

By Lu Z-J   Zhou S-H   Yan S-X   Yao H-T  

The Journal of International Medical Research, Vol. 37, Iss. 6, 2009-11 ,pp. : 2000-2008

Field House Publishing

Access to resources Recommend Favorite

Recent Development in the Discovery of Anaplastic Lymphoma Kinase (ALK) Inhibitors for Non-small Cell Lung Cancer

By  

Current Medicinal Chemistry, Vol. 24, Iss. 6, 2017-03 ,pp. : 590-613

Bentham Science Publishers

Access to resources Recommend Favorite

Inhibitors of the anaplastic lymphoma kinase

By Mologni Luca  

Expert Opinion on Investigational Drugs, Vol. 21, Iss. 7, 2012-07 ,pp. : 985-994

Informa Healthcare

Access to resources Recommend Favorite

Partial deletion of the ALK gene in ALK‐positive anaplastic large cell lymphoma

By  

Hematological Oncology (Electronic), Vol. 36, Iss. 1, 2018-02 ,pp. : 150-158

John Wiley & Sons Inc

Access to resources Recommend Favorite

Anaplastic lymphoma kinase as a therapeutic target

By Kruczynski Anna   Delsol Georges   Laurent Camille   Brousset Pierre   Lamant Laurence  

Expert Opinion on Therapeutic Targets, Vol. 16, Iss. 11, 2012-11 ,pp. : 1127-1138

Informa Healthcare

Access to resources Recommend Favorite